20894 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Tachykinins, e.g. eledoisins, substance P; Related peptides
SKIN MICROENVIRONMENT TARGETED DELIVERY FOR PROMOTING IMMUNE AND OTHER RESPONSES
#2SKIN MICROENVIRONMENT TARGETED DELIVERY FOR PROMOTING IMMUNE AND OTHER RESPONSES
#3Compound with analgesic effect for use in prevention and treatment of pain
#4COMBINATION THERAPY OF SUBSTANCE-P FOR MOBILIZATION OF HEMATOPOIETIC STEM CELLS
#5Use of Non-Peptidic NK1 Receptor Antagonists for the Production of Apoptosis in Tumour Cells
#6Compound with analgesic effect for use in prevention and treatment of pain
#7PREFABRICATED ALGINATE-DRUG BANDAGES
#8Noxipoints stimulating devices using light, mechanical force, or heat as a source of stimulation
#9METHODS AND COMPOSITIONS FOR THE MODULATION OF BETA-ENDORPHIN LEVELS
#10NK3 agonist for use in the treatment of a patient suffering from atrial arrhythmia or fibrillation
#11Skin microenvironment targeted delivery for promoting immune and other responses
#12Prefabricated alginate-drug bandages
#13SUBSTANCE P, MAST CELL DEGRANULATION INHIBITORS, AND PERIPHERAL NEUROPATHY
#14Method of treating a wound, comprising the step of administering a composition including a substance P
#15USE OF NON-PEPTIDIC NK1 RECEPTOR ANTAGONISTS FOR THE PRODUCTION OF APOPTOSIS IN TUMOUR CELLS
#16Pharmaceutical composition for preventing or treating arthritis
#17SUBSTANCE AND METHOD FOR TREATING INFLUENZA
#18Bifunctional compounds for relief of pain comprising an opioid receptor agonist moiety and a NK1 receptor antagonist moiety and methods for treating pain
#19Prefabricated alginate-drug bandages
#20Method for reversing recent-onset type 1 diabetes (T1D) by administering substance P (sP)
#21Methods of administration of Substance P for wound healing
#22COMPOSITIONS AND METHODS FOR MOBILIZATION OF STEM CELLS
#23AGENT FOR STIMULATING MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS
#24Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents
#25Hydrogel Type Cell Delivery Vehicle for Wound Healing, and Preparation Method Thereof
#26System and method for inhibiting cellular proliferation with tachykinins
#27MODULATORS OF PARAPTOSIS AND RELATED METHODS
#28ACUTE RESPIRATORY SYNDROMES
#29USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#30METHOD FOR REDUCING INTRACRANIAL PRESSURE
#31USE OF AGENTS THAT DOWN-REGULATE EXPRESSION OF TANIS AND/OR P21 Waf1/Cip1/Sd1 GENES, AND USE OF AGENTS THAT INHIBIT, DEGRADE, SEQUESTER OR PREVENT THE NEUROTOXICITY OF GENE PRODUCT PROTEINS OF TANIS AND P21 Waf1/Cip1/Sd1 GENES
#32COMPOSITION FOR PREVENTION OR TREATMENT OF BONE MARROW DAMAGE
#33Methods of using substance P to promote healing of vascular wounds
#34METHOD TO TREAT BLOOD CELL DEPLETION
#35STIMULATION OF TRPV1+ SENSORY NEURONS TO CONTROL BETA-CELL STRESS AND ISLET INFLAMMATION IN DIABETES
#36Trophic factor combinations for nervous system treatment
#37Treatment of asthma
#38TRPV1 + SENSORY NEURONS CONTROL OF BETA-CELL STRESS AND ISLET INFLAMMATION IN DIABETES
#39USE OF AGENTS THAT PREVENT THE GENERATION OF AMYLOID-LIKE PROTEINS AND/OR DRUSEN, AND/OR USE OF AGENTS THAT PROMOTE SEQUESTRATION AND/OR DEGRADATION OF, AND/OR PREVENT THE NEUROTOXIC EFFECTS OF SUCH PROTEINS IN THE TREATMENT OF MACULAR DEGENERATION
#40USE OF AGENTS THAT PREVENT GENERATION OF AMYLOID AND AMYLOID-LIKE LIPOPROTEINS, AND/OR USE OF AGENTS THAT PROMOTE SEQUESTRATION AND/OR DEGRADATION OF, AND/OR PREVENT NEUROTOXICITY OF SUCH PROTEINS IN THE TREATMENT OF HEARING LOSS AND IMPROVING BODY BALANCE
#41METHOD TO REDUCE THE RISK AND/OR SEVERITY OF ANTHRAX INFECTION
#42Method for inhibiting or treating intestinal damage caused by radiotherapy or chemotherapy comprising administering substance-P
#43METHODS FOR STIMULATING FIBROBLAST PROLIFERATION USING SUBSTANCE P ANALOGS
#44Method of using substance P analogs for treatment amelioration of myelodysplastic syndrome
#45MODULATORS OF PARAPTOSIS AND RELATED METHODS
#46Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents
#47METHODS FOR TREATING NEUROGENIC INFLAMMATION
#48METHODS FOR TREATING NEUROGENIC INFLAMMATION
#49Use of non-peptidic NK1 receptor antagonists for the production of apoptosis in tumour cells
#50Method to Promote Wound Healing
#51Treatment of Skin Diseases
#52TRPV1 sensory neurons control of β-cells stress and islet inflammation in diabetes
#53Method for identifying agonists or antagonists of the G-protein coupled receptor mas-like 1
#54Substance P treatment for hepatitis C
#55Trophic factor combinations for nervous system treatment
#56Amelioration of effects of cigarette smoke
#57Acute respiratory syndromes
#58Methods and compositions using Substance P to promote wound healing
#59Compositions and methods for modulating angiogenesis
#60Use of neuropeptides for traumatic cartilage injury
#61Compositions and regime/regimen for treating the adverse signs of cutaneous skin aging
#62Cytomodulating peptides for treating interstitial cystitis
#63Stimulation of hair regrowth
#64Use of substance P for mobilization of Mesenchymal stem cells or proliferation of Mesenchymal stem cells and for wound healing or facilitating wound healing
#65Use of agents that prevent the generation of amyloid-like proteins and/or drusen, and/or use of agents that promote sequestration and/or degradation of, and/or prevent the neurotoxic effects of such proteins in the treatment of macular degeneration
#66Methods for treating inflammation pain
#67Use of neuropeptides for ligament healing
#68Process for the production of implants
#69Ghrelin receptor inverse agonists for regulation of feeding behaviors
#70Lactone bearing absorbable polymers
#71Modulators of paraptosis and related methods
#72System and method for inhibiting cellular proliferation with tachykinins
#73Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
#74Method for treating glaucoma comprising administering α-lipoic acid
#75Use of agents that prevent generation of amyloid and amyloid-like lipoproteins, and/or use of agents that promote sequestration and/or degradation of, and/or prevent neurotoxicity of such proteins in the treatment of hearing loss and improving body balance
#76Hair-follicle treatment,in particular against hair loss